Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI
Publication | 09.01.13
Contacts
Insights
Publication | 11.24.25
Litigation Funders Looking to Invest in Law Firms Face Hurdles
Publication | 11.19.25
Who Can Fix It? Antitrust, IP Rights, and the Right to Repair
Publication | 11.14.25
Three Steps Tech Companies Can Take Today To Prepare To Ride A Blue Wave In 2026
